Home NDC 68462-208 Moexipril Hydrochloride
Product NDC 68462-208
11-digit product format 684620208
Labeler code 68462
Product ID 68462-208_66bb1c8f-1f66-4834-86a3-a387d076aa22
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Moexipril Hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Glenmark Pharmaceuticals Inc., USA
Application ANDA090416
Marketing category ANDA
Marketing start 2010-12-31
Substance MOEXIPRIL HYDROCHLORIDE
Active strength 15 mg/1
Pharmacologic classes Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090416-001 MOEXIPRIL HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 A090416-002 MOEXIPRIL HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A090416-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2010-03-30 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A090416-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB 2010-03-30 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Moexipril Hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MOEXIPRIL HYDROCHLORIDE 15 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination Q1UMG3UH45 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1299896 Internal RxNorm lookup 1299897 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 68462-208-01 Moexipril Hydrochloride 100 in 1 BOTTLE TABLET, FILM COATED 100 12 68462-208-10 Moexipril Hydrochloride 1000 in 1 BOTTLE TABLET, FILM COATED 1000 12 68462-208-90 Moexipril Hydrochloride 90 in 1 BOTTLE TABLET, FILM COATED 90 12
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MOEXIPRIL HYDROCHLORIDE ACTIVE INGREDIENT Q1UMG3UH45 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 MOEXIPRILAT ACTIVE MOIETY H3753190JS MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 MAGNESIUM OXIDE INACTIVE INGREDIENT 3A3U0GI71G MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 POLYETHYLENE GLYCOL 6000 INACTIVE INGREDIENT 30IQX730WE MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 POVIDONES INACTIVE INGREDIENT FZ989GH94E MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 68462-208 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] 11 Current NDC, Legacy NDC, 3 package rows 20240423_baac91ad-f8ee-4694-89f8-5c47a8eda39a.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 68462-208-01 68462020801 100 TABLET, FILM COATED in 1 BOTTLE (68462-208-01) 2010-12-31 0000-00-00 No No Current 68462-208-10 68462020810 1000 TABLET, FILM COATED in 1 BOTTLE (68462-208-10) 2010-12-31 0000-00-00 No No Current 68462-208-90 68462020890 90 TABLET, FILM COATED in 1 BOTTLE (68462-208-90) 2010-12-31 0000-00-00 No No Current